We are using cookies to implement functions like login, shopping cart or language selection for this website. Furthermore we use Google Analytics to create anonymized statistical reports of the usage which creates Cookies too. You will find more information in our privacy policy.
OK, I agree I do not want Google Analytics-Cookies
The International Journal of Oral & Maxillofacial Implants



Forgotten password?


Int J Oral Maxillofac Implants 12 (1997), No. 5     1. Sep. 1997
Int J Oral Maxillofac Implants 12 (1997), No. 5  (01.09.1997)

Page 604-610

Bone Formation and Reosseointegration in Peri-implantitis Defects Following Surgical Implantation of rhBMP-2
Hanisch / Tatakis / Boskovic / Rohrer / Wikesjo
This study was designed to evaluate bone formation and reosseointegration following surgical implantation of recombinant human bone morphogenetic protein-2 (rhBMP-2) in peri-implantitis defects. Hydroxyapatite-coated dental implants were placed bilaterally in the mandibular and maxillary premolar area in four rhesus monkeys and were allowed to osseointegrate for 1 year. Cotton ligatures were then placed around the healinga butments, and plaque was allowed to accumulate for 11 months. Resulting circumferential peri-implantitis defects exhibited a large intrabony and horizontal component. At reconstructive surgery, peri-implantitis defects in contralateral jaw quadrants were randomly assigned to receive rhBMP-2 (0.43 mg/mL implant volume) in an absorbable collagen sponge carrier or a carrier control. The animals were sacrificed 4 months postsurgery, and block sections were preared for histometric analysis. Summary statistics included means calculated per animal. Paired t tests were used to evaluate differences between experimental conditions (n = 4). Defect depth amounted to 3.4 ± 0.9 mm and 3.2 ± 0.9 mm for rhBMP-2 and control defects, respectively. Vertical bone gain in rhBMP-2 defects (2.6 ± 1.2 mm) was significantly greater than in controls (.08 ± 0.8 mm; P < .01). Reosseointegration within the confines of the defect for rhBMP-2 defects (29.0 ± 10.5%) differed significantly from that in the control (3.5 ± 2.5%; P < .01). Reosseointegration within the extent of newly formed bone averaged 40.0 ± 11.0% in rhBMP-2 defects as compared to 8.9 ± 7.8% in the control (P < .01). Osseointegration in resident bone amounted to 69.5 ± 6.9% and 72.6 ± 8.0% for rhBMP-2 and control defects, respectively. There is significant evidence that rhBMP-2 has potential to promote bone formation and reosseointegration in advanced peri-implantitis defects in a demanding nonhuman primate model.